HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$4.17
Day range
$4.31 - $4.65
Year range
$3.35 - $10.32
Market cap
130.44M USD
Avg Volume
71.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 7.36M | 59.67% |
Operating expense | 14.63M | -4.24% |
Net income | -4.33M | 69.00% |
Net profit margin | -58.83 | 80.58% |
Earnings per share | — | — |
EBITDA | -7.98M | 29.28% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.48M | 322.16% |
Total assets | 32.43M | 92.92% |
Total liabilities | 56.58M | 67.09% |
Total equity | -24.15M | — |
Shares outstanding | 29.31M | — |
Price to book | -4.69 | — |
Return on assets | -81.22% | — |
Return on capital | 117.69% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.33M | 69.00% |
Cash from operations | -13.42M | -45.32% |
Cash from investing | -60.00K | -100.00% |
Cash from financing | 25.99M | 305.95% |
Net change in cash | 12.51M | 536.99% |
Free cash flow | -9.85M | -438.06% |
About
Founded
2009
Headquarters
Website
Employees
107
